SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma

por Heusschen, Roy, Muller, Joséphine, Binsfeld, Marilène, Marty, Caroline, Plougonven, Erwan, Dubois, Sophie, Mahli, Nadia, Moermans, Karen, Carmeliet, Geert, Léonard, Angélique, Baron, Frédéric, Beguin, Yves, Menu, Eline, Cohen-Solal, Martine, Caers, Jo
Publicado 2016